Advertisement

Alere Inc. (NYSE:ALR) has developed a test that can now detect the main cause of pre-eclampsia, a condition when an pregnant women experiences high blood pressure and protein in the urine. The Waltham health-care management company said Monday that results of a UK-based study showed that its Alere Triage blood test, which measures the placental growth factor (PlGF), can quantify risk in women when pre-eclampsia, a condition that can develop during pregnancy, is detected.

Advertisement
Advertisement